logo
logo

RevOpsis Therapeutics secures investment from ExSight Ventures to accelerate preclinical development and expand its pipeline.

Sep 16, 2025•5 days ago
SpringfieldBiotechnology

Investors

Ex Sight Ventures

Description

RevOpsis Therapeutics, a biotechnology company, received an investment from ExSight Ventures. The amount of the deal was not disclosed. The company plans to use the funds to accelerate the preclinical development of its lead candidate. They are focused on treating significant unmet needs in ophthalmology.

Company Information

Company

RevOpsis Therapeutics

Location

Springfield, Illinois, United States

About

RevOpsis Therapeutics is a next-generation biopharmaceutical company that is trailblazing a new era in multispecific antibody discovery and development to unlock transformative treatments for complex disease.

Related People

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers